J M Ledeine

Suggest Changes
Learn More
BACKGROUND Gatifloxacin is an 8-methoxyfluoroquinolone with good activity against respiratory pathogens. OBJECTIVES To document the bacteriologic and clinical efficacy of gatifloxacin in(More)
OBJECTIVE We sought to evaluate the effects of muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor (PPAR) activator within the new glitazar class, on hyperglycemia and lipid(More)
CONTEXT The therascreen KRAS RGQ polymerase chain reaction kit is being developed as a companion diagnostic to aid clinicians, through detection of KRAS mutations, in the identification of patients(More)
  • 1